@article{6c09c84833354d8fa0dec46b042d06b2,
title = "Replication-competent retroviruses in gene-modified T cells used in clinical trials: Is it time to revise the testing requirements?",
author = "Bear, {Adham S.} and Morgan, {Richard A.} and Kenneth Cornetta and June, {Carl H.} and Gwendolyn Binder-Scholl and Dudley, {Mark E.} and Feldman, {Steven A.} and Rosenberg, {Steven A.} and Shurtleff, {Sheila A.} and Rooney, {Cliona M.} and Heslop, {Helen E.} and Gianpietro Dotti",
note = "Funding Information: This work was supported in part by grants from the Leukemia and Lymphoma Society Specialized Center of Research (SCOR; grant 7018), the National Institutes of Health (NIH) (3P50CA126752, P01CA094237, and 5U54HL081007), and the National Center for Research Resources/NIH National Gene Vector Biorepository program (P40 RR024928). The authors declared no conflict of interest.",
year = "2012",
month = feb,
doi = "10.1038/mt.2011.288",
language = "English (US)",
volume = "20",
pages = "246--249",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "2",
}